Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-02-16
1989-05-02
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544255, A61K 31505, C07D51304
Patent
active
048268488
ABSTRACT:
Novel substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines useful as anti-depressives, in the treatment of Parkinson's disease and in the treatment of diseases related with disturbed enterokinesia.
REFERENCES:
patent: 3953461 (1976-04-01), Denzel et al.
patent: 4224333 (1980-09-01), Clemence et al.
patent: 4342761 (1982-08-01), Ward
Burger's Medicinal Chemistry, Fourth Edition, Part III, Manfred E. Wolff (Ed.), pp. 943-944, John Wiley, New York, 1981.
Colpaert, F. et al., Drug Development Research vol. 8, pp. 361-371 (1986).
Boar Bernard R.
Janssens Frans E.
Stokbroekx Raymond A.
Van Offenwert Theophilus T. J. M.
Janssen Pharmaceutica N.V.
Levy David J.
Schwartz Richard A.
LandOfFree
Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic con does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic con, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic con will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-585214